Frequency Therapeutics Total Assets 2011-2026 | FREQ

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Frequency Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
114 M	226 M	222 M	73.7 M	185 M	265 M	223 M	44.5 M	19.8 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
265 M	19.8 M	153 M

Quarterly Total Assets Frequency Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
162 M	180 M	202 M	226 M	244 M	250 M	198 M	222 M	46.3 M	79.4 M	102 M	121 M	136 M	150 M	165 M	185 M	202 M	220 M	242 M	265 M	265 M	265 M	265 M	223 M	223 M	223 M	223 M	44.5 M	44.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
265 M	44.5 M	185 M

Total Assets of other stocks in the Biotechnology industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
ADC Therapeutics SA ADCT	529 M	$ 3.78	-	$ 105 M	Schweiz
MorphoSys AG MOR	2.03 B	-	2.43 %	$ 254 M	Germany
Akebia Therapeutics AKBA	377 M	$ 1.35	-2.17 %	$ 347 M	USA
Akari Therapeutics, Plc AKTX	47.9 M	$ 3.5	-21.7 %	$ 236 B	Britain
Aldeyra Therapeutics ALDX	72.1 M	$ 1.58	-4.82 %	$ 94.9 M	USA
Aligos Therapeutics ALGS	88.5 M	$ 8.36	4.89 %	$ 82.6 M	USA
Alnylam Pharmaceuticals ALNY	4.97 B	$ 330.71	3.72 %	$ 43.3 B	USA
Altimmune ALT	280 M	$ 3.47	3.89 %	$ 306 M	USA
ALX Oncology Holdings ALXO	59 M	$ 1.98	0.25 %	$ 106 M	USA
Amgen AMGN	90.6 B	$ 346.45	-0.43 %	$ 186 B	USA
I-Mab IMAB	6.33 B	-	-	$ 866 M	China
Amneal Pharmaceuticals AMRX	3.68 B	$ 12.37	-0.92 %	$ 3.88 B	USA
Alexion Pharmaceuticals, Inc. ALXN	18.1 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	151 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	12 M	-	-13.47 %	$ 169 M	France
Anika Therapeutics ANIK	271 M	$ 15.0	1.32 %	$ 220 M	USA
ANI Pharmaceuticals ANIP	1.28 B	$ 76.34	2.87 %	$ 1.47 B	USA
Annexon ANNX	278 M	$ 5.64	2.45 %	$ 875 M	USA
Aptorum Group Limited APM	16.1 M	$ 0.92	-1.11 %	$ 5.02 M	China
Midatech Pharma plc MTP	14.8 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	15.2 M	-	-1.52 %	$ 24.7 M	USA
Aprea Therapeutics APRE	15.9 M	$ 0.73	2.63 %	$ 4.77 M	USA
Aquestive Therapeutics AQST	160 M	$ 4.15	0.48 %	$ 444 M	USA
Arcturus Therapeutics Holdings ARCT	271 M	$ 8.43	4.98 %	$ 231 M	Israel
Ardelyx ARDX	502 M	$ 6.08	2.27 %	$ 1.47 B	USA
argenx SE ARGX	8.68 B	$ 752.05	0.75 %	$ 25 B	Niderland
Acorda Therapeutics ACOR	109 M	-	-24.86 %	$ 820 K	USA
Arcutis Biotherapeutics ARQT	433 M	$ 23.93	1.27 %	$ 3.04 B	USA
Arvinas ARVN	718 M	$ 11.11	2.4 %	$ 788 M	USA
Adverum Biotechnologies ADVM	180 M	-	-	$ 86.2 M	USA
Arrowhead Pharmaceuticals ARWR	1.39 B	$ 61.57	0.88 %	$ 8.24 B	USA
Advaxis ADXS	16.6 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	107 M	-	-	$ 10.1 M	USA
Assembly Biosciences ASMB	258 M	$ 30.01	3.43 %	$ 336 M	USA
Aeterna Zentaris AEZS	35.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.95 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	113 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	778 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.7 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	826 M	-	-	$ 3.67 B	USA
Akouos AKUS	279 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	1.51 B	-	-	-	Russia
Actinium Pharmaceuticals ATNM	51.8 M	$ 1.14	16.28 %	$ 35.6 M	USA
Atossa Therapeutics ATOS	47.6 M	$ 5.21	-2.89 %	$ 44.9 M	USA
Atara Biotherapeutics ATRA	20.2 M	$ 5.03	0.7 %	$ 63.1 M	USA
Allena Pharmaceuticals ALNA	34.8 M	-	3.16 %	$ 1.9 M	USA
Aurinia Pharmaceuticals AUPH	752 M	$ 16.04	2.75 %	$ 2.16 B	Canada
Autolus Therapeutics plc AUTL	589 M	$ 1.42	0.35 %	$ 378 M	Britain
Alpine Immune Sciences ALPN	287 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	24.2 M	-	10.36 %	$ 9.8 M	USA